Zwart, Tom C. http://orcid.org/0000-0003-3692-0901
Moes, Dirk Jan A. R.
van der Boog, Paul J. M.
van Erp, Nielka P.
de Fijter, Johan W.
Guchelaar, Henk-Jan
Keizer, Ron J.
ter Heine, Rob
Article History
First Online: 27 July 2020
Declarations
:
: Nielka P. van Erp’s institution has received research grants from Astellas, Novartis, Ipsen, and Janssen-Cilag and consulting fees from Bayer and Sanofi, none of which were related to the content of this article. Ron J. Keizer is a founder, employee and stockholder for InsightRX. Tom C. Zwart, Dirk Jan A.R. Moes, Paul J.M. van der Boog, Johan W. de Fijter, Henk-Jan Guchelaar and Rob ter Heine have no conflicts of interest that are directly relevant to the content of this article.
: The NONMEM code used to generate and/or analyse the data described in this study is provided in the ESM.
: No funding was received for this study.
: This research study was conducted retrospectively with data obtained for clinical purposes. We consulted with the scientific committee of the Department of Internal Medicine of Leiden University Medical Center, who determined that our study did not need ethical approval or informed consent.